Neil W. Gibson

CIK: 0001555918

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TIL

Instil Bio, Inc.

Director

STTK

Shattuck Labs, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

TIL
Instil Bio, Inc.
Jun 11, 2026
Award(A)
Stock Option (Right to Buy)
Direct
0 shares-
STTK
Shattuck Labs, Inc.
May 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
81K shares-
STTK
Shattuck Labs, Inc.
Jul 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
33.2K shares-
TIL
Instil Bio, Inc.
May 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
6.5K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	TIL Instil Bio, Inc.	Award(A) Stock Option (Right to Buy)	0	-	-	Direct
May 29, 2026	STTK Shattuck Labs, Inc.	Award(A) Stock Option (Right to Buy)	81,000	-	-	Direct
Jul 14, 2025	STTK Shattuck Labs, Inc.	Award(A) Stock Option (Right to Buy)	33,150	-	-	Direct
May 28, 2025	TIL Instil Bio, Inc.	Award(A) Stock Option (Right to Buy)	6,500	-	-	Direct

1-4 of 4 transactions

About Gibson Neil W

Gibson Neil W (SEC CIK 0001555918) files insider reports with the SEC as Director of Instil Bio, Inc. (TIL) and Director of Shattuck Labs, Inc. (STTK).

Signal8 holds 4 ownership filings by Gibson Neil W, all Form 4s, filed between May 29, 2025 and Jun 12, 2026. Those filings report 4 transactions, from May 28, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gibson Neil W's filings is in AUSTIN, TX.

Recent filings by Gibson Neil W

Jun 11, 2026: Grant or award of TIL derivative securities (Form 4, code A).
May 29, 2026: Grant or award of STTK derivative securities (Form 4, code A).
Jul 14, 2025: Grant or award of STTK derivative securities (Form 4, code A).
May 28, 2025: Grant or award of TIL derivative securities (Form 4, code A).

Other insiders filing for Instil Bio, Inc. (TIL)

McGaughy R Kent Jr, Director
Matcham George, Director
Binder Gwendolyn, Director
Laumas Sandeep, CFO and CBO
Crouch Bronson, CEO and Chairman

How to read Form 4 transaction codes